Literature DB >> 9243651

A comparison of participants with non-participants in a population-based epidemiologic study: the Melbourne Visual Impairment Project.

P M Livingston1, S E Lee, C A McCarty, H R Taylor.   

Abstract

PURPOSE: Adequate participation in population-based studies in essential to ensure that the sample is representative of the population under investigation. Participants may differ from non-participants on important variables such as age, sex socioeconomic status, and general health factors. The Melbourne Visual Impairment Project (Melbourne VIP) is a population-based study designed to increase understanding of the prevalence and severity of common ocular disorders affecting people 40 years of age and over. AIM: The aim of this study was to determine the potential for any non-response bias by comparing data from participants and non-participants of the Melbourne VIP.
METHODS: Specific demographic and general variables were compared between the two groups. The variables included age, sex, education level, and social status. The reason for non-attendance was also recorded.
RESULTS: A total of 3271 (83%) eligible residents from the 9 sample areas were screened; 46% males and 54% females. Language spoken at home was significantly associated with participation. Residents whose main language at home was not English were less likely to attend the screening centre. (OR: 0.60; CI: 0.44-0.81). The main reasons given for non-attendance by eligible residents were lack of interest (6%), too busy to attend (4%), personal illness (2%), and attend own eye specialist (2%).
CONCLUSION: We believe these results will not impact significantly on the interpretation of gender and age-specific data from the Melbourne VIP.

Entities:  

Mesh:

Year:  1997        PMID: 9243651     DOI: 10.3109/09286589709057099

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  14 in total

1.  Utilisation of eye care services by urban and rural Australians.

Authors:  Jill E Keeffe; LeAnn M Weih; Cathy A McCarty; Hugh R Taylor
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Epidemiology of pterygium in Victoria, Australia.

Authors:  C A McCarty; C L Fu; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

3.  A demonstration of the impact of response bias on the results of patient satisfaction surveys.

Authors:  Kathleen M Mazor; Brian E Clauser; Terry Field; Robert A Yood; Jerry H Gurwitz
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

4.  Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project.

Authors:  R McKay; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

5.  The need for cataract surgery: projections based on lens opacity, visual acuity, and personal concern.

Authors:  C A McCarty; J E Keeffe; H R Taylor
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

6.  Vision impairment predicts five-year mortality.

Authors:  H R Taylor; C A McCarty; M B Nanjan
Journal:  Trans Am Ophthalmol Soc       Date:  2000

7.  Vision impairment predicts 5 year mortality.

Authors:  C A McCarty; M B Nanjan; H R Taylor
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

8.  Self-reported visual impairment and impact on vision-related activities in an elderly Nigerian population: report from the Ibadan study of ageing.

Authors:  Charles O Bekibele; Oye Gureje
Journal:  Ophthalmic Epidemiol       Date:  2008 Jul-Aug       Impact factor: 1.648

9.  Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project.

Authors:  C A McCarty; C W Lloyd-Smith; S E Lee; P M Livingston; Y L Stanislavsky; H R Taylor
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

10.  Knowledge, attitudes, and self care practices associated with age related eye disease in Australia.

Authors:  P M Livingston; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.